Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts.

The number of people making five or more emergency visits to hospital a year with lung difficulties has almost tripled in some parts of England, an analysis has found. The charity Asthma + Lung UK ...

Various types of inhalers, including short- and long-lasting options, are available for managing chronic obstructive pulmonary disease (COPD). A person can get a COPD inhaler through Medicare Part ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The AeroVax study, supported by $8M in funding from the Canadian Institutes ...

inhalers for people with asthma, and cholesterol drugs and testing for people with heart disease. Roughly 53% of employers offer HDHPs to their employees, and an estimated 129 million people in ...

Emond emphasized the significance of the report, highlighting that over 15 million Americans suffer from COPD ... inhalers. Breo Ellipta, a dual-therapy inhaler combining an ICS and LABA, was ...

Emond emphasized the significance of the report, highlighting that over 15 million Americans suffer from COPD ... containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA) ...

IFN-γ in COPD; Acute and chronic infection; for example, viral, bacterial, fungal colonization, and so on. Endotyping clinical phenoptyes based on pathobiology and response to medications can ...

Symptoms may range from mild to severe. People whose symptoms only worsen while resting require treatment. Certain medications can prevent or treat this condition. The best altitude sickness ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...